FleishmanHillard Expands Health and Life Sciences Global Leadership Team

Stock.adobe.com

Mary Kosinski is the new global managing director of health and life sciences at FleishmanHillard.¹ The PR agency announced the appointment in a press release, where it described health and life sciences as its largest sector. Kosinski is responsible for driving transformation and expanding focus.

Kosinski previously worked Pi Health as head of global affairs. Prior to that, she spent 15 years at the US Department of Health and Human Services, where she worked both domestically and internationally.

In a press release, Kosinski said, “I'm excited to join such a dynamic organization and talented team at such a pivotal moment for the healthcare industry. The pace of change is unlike any other in healthcare's history–digital transformation, Gen AI, patient-centered care and novel drugs and therapeutics are all contributing to a new era where communications is vital in helping clients meet patient and consumer expectations. FleishmanHillard's deep health and life sciences experience will ensure we're ready to help clients achieve their goals and navigate the challenges they face with the agility, thought leadership and expert support they need."

In the same press release, FleishmanHillard’s global head of practices and sectors Mark Mortell said, “Mary's energy and deep regulatory and policy experience will bring tremendous insights to our clients and fresh perspectives to our team. Her background in government agencies complements FleishmanHillard's strong healthcare credentials and expertise across the sector."

Alongside Kosinski, FleishmanHillard announced the expansion of its leadership team in health and life sciences with three additional roles being added to the roster. This includes John Grisborne as global head of strategic client partnerships, Marc Longpre as global head of strategy and insights, and Jenyne Engelhardt as global head of operations and integration.

Mortell is a recent addition to the firm’s global leadership team. He was announced as part of a group of leadership additions in November 2024, along with Lisa Moehlenhamp as chief operating officer, Emily Frager as chief client officer, Mitch Germann as chief business development and brand officer, Ephraim Cohen as global head of data and digital, and Faith Howe as chief of staff.²

In a press release issued at the time, president and CEO J.J. Carter said, “As we accelerate the modernization of our firm, these appointments are vital to our future. By fortifying our operations with proven agency leaders and elevating new voices, we will fuel our growth and the transformation of our work. This first phase of appointments strengthens accountability for client operations, business development, industry expertise, data and digital, and preparing our workforce for change. On this foundation we will expand our use of intelligence and technology, while becoming a more dynamic, modern consultancy."

Sources

1. FleishmanHillard Appoints Mary Kosinski as Global Managing Director of Health and Life Sciences. FleishmanHillard. January 7, 2025. https://www.prnewswire.com/news-releases/fleishmanhillard-appoints-mary-kosinski-as-global-managing-director-of-health-and-life-sciences-302344294.html
2. FleishmanHillard Announces Wave of New Global Leadership Appointments. FleishmanHillard. November 21, 2024. Accessed January 8, 2025. https://www.prnewswire.com/news-releases/fleishmanhillard-announces-wave-of-new-global-leadership-appointments-302312930.html